Enter inventor name

Karen Elizabeth Lackey

USPTO Granted Patents = 28 (Patent Applications = 6)

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 583(Granted Patents)

Location History:

Hillsborough, NC (US) (2001 - 2013)
Durham, NC (US) (2000 - 2015)

Company Filing History:

20 out of 2,198

Smithkline Beecham Corporation

Smithkline Beecham (cork) Ltd

Years Active: 2000-2015

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9199973 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2015-12-01),

2. 8912205 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2014-12-16),

3. 8513262 - Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors (2013-08-20),

4. 8444988 - Cancer treatment method (2013-05-21),

5. 7507741 - Heterocyclic compounds (2009-03-24),

6. 7338966 - Substituted oxindole derivatives as tyrosine kinase inhibitors (2008-03-04),

7. 7265123 - Heterocyclic compounds (2007-09-04),

8. 7189734 - Anilinoquinazaolines as protein tyrosine kianse inhibitors (2007-03-13),

9. 7141576 - Cancer treatment method (2006-11-28),

10. 7129253 - Compounds (2006-10-31),

11. 7109333 - Heterocyclic compounds (2006-09-19),

12. 7105529 - Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects (2006-09-12),

13. 7084147 - Anilinoquinazaolines as protein tyrosine kinase inhibitors (2006-08-01),

14. 7071217 - Substituted oxindole derivatives as tyrosine kinase inhibitors (2006-07-04),

15. 7015231 - Chemical compounds (2006-03-21),

Title: The Innovative Contributions of Karen Elizabeth Lackey

Introduction: Karen Elizabeth Lackey, based in Durham, NC, has made significant strides in the field of pharmaceuticals and biochemistry. With an impressive portfolio of 28 patents, her work has had a profound impact on medical research and drug development.

Latest Patents: Among her notable contributions, Lackey's latest patents include groundbreaking advancements in "Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors." These pharmaceutical formulations focus on innovative compounds designed to inhibit key proteins involved in various diseases, showcasing her dedication to advancing medical science.

Career Highlights: Karen Lackey has held prominent positions in leading pharmaceutical companies, including SmithKline Beecham Corporation and Glaxo Wellcome Inc. Her expertise in biochemistry and pharmacology has contributed to substantial progress within these reputable organizations, driving research initiatives and product development.

Collaborations: Throughout her career, Lackey has collaborated with esteemed colleagues such as George Stuart Cockerill and Lee Frederick Kuyper. These partnerships have not only enriched her research experience but have also fostered an environment of innovation, leading to successful advancements in drug discovery.

Conclusion: Karen Elizabeth Lackey exemplifies the spirit of innovation inherent in the field of pharmaceuticals. Her numerous patents and collaborative efforts highlight her commitment to improving healthcare through scientific research and development. As she continues to pave the way for new breakthroughs, her contributions will undoubtedly resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com